Atopic Dermatitis
-
healthReduced Infant Bathing Linked to Lower Eczema Rates in Early Trial
A new feasibility study suggests that bathing infants less frequently may reduce their risk of developing eczema by six months of age.
-
healthFDA-Approved Biologic Dupilumab Shows Strong Efficacy in Children with Eczema
A systematic review finds dupilumab significantly improves disease severity and quality of life in children with moderate-to-severe atopic dermatitis.
-
healthExtended Steroid Treatment in Atopic Dermatitis Tied to More Health Complications
A German study shows that each additional three months of systemic glucocorticosteroids for atopic dermatitis raises risks for osteoporosis, diabetes, hypertension, and mental health disorders, with duration outweighing total dose.
-
healthLockdown-Born Children Show Persistent Drop in Food Allergies
A longitudinal study from Ireland reveals children born during COVID-19 lockdowns maintain lower food allergy rates at age five, likely due to reduced antibiotic exposure.
-
healthChildhood Eczema Can Scar Career and Education for Life
Large global study finds childhood atopic dermatitis has lasting effects on education, careers, and psychosocial health, even after symptoms clear.
-
healthEarly Atopic Dermatitis Elevates Childhood Asthma Risk
Study reveals a significant link between early-onset atopic dermatitis and heightened asthma risk in children, highlighting key contributing factors and implications for early intervention.
-
healthAtopic Dermatitis Study Debunks Academic Performance Link
New research indicates atopic dermatitis in children does not significantly impact academic achievement, offering reassurance to families and educators.
-
healthUpadacitinib Maintains Safety Across Age Groups in Atopic Dermatitis
Long-term safety data from Phase III studies show upadacitinib is effective for moderate-to-severe atopic dermatitis across age groups, with specific considerations for older adults and higher doses.